Parameter coefficients from multivariable analysis of predictors of quality of life, evaluated separately for each of the functioning and symptom scales in the IPTW-adjusted cohort
Variables included in each multivariable model | Functioning scales* | Symptom scales† | ||||||
Global QoL | Physical | Role | Emotional | Cognitive | Social | Fatigue | Pain | |
Intercept | 90.97‡ | 138.49‡ | 126.18‡ | 73.39‡ | 87.70‡ | 99.58‡ | 4.59 | −0.77 |
Age at survey (years, reference is age 0) | −0.08 | −0.63‡ | −0.41‡ | 0.25‡ | 0.13 | −0.02 | 0.11 | 0.12 |
LEL and BMI category | ||||||||
No LEL and BMI <30 (reference) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No LEL and BMI 30–39.9 | −6.52‡ | −5.27‡ | −2.89 | −2.61 | −1.92 | −2.02 | −0.32 | −1.00 |
No LEL and BMI 40+ | −6.42 | −10.97‡ | −7.33 | −3.80 | −4.00 | −0.20 | 3.56 | 0.70 |
LEL and BMI <30 | −6.94 | −4.22 | −12.47‡ | −7.32 | 0.41 | −4.54 | 10.03‡ | 9.03 |
LEL and BMI 30–39.9 | −18.13‡ | −15.74‡ | −12.64‡ | −8.17‡ | −10.18‡ | −13.75‡ | 18.83‡ | 19.48‡ |
LEL and BMI at 40+ | −19.70‡ | −33.08‡ | −31.11‡ | −13.24‡ | −22.19‡ | −30.66‡ | 19.97‡ | 29.26‡ |
History of diabetes at time of survey | 0.44 | −6.74‡ | −3.60 | −1.55 | −5.58‡ | −4.80 | 1.97 | 6.57‡ |
History of heart failure or congestive heart failure at time of survey | −6.25 | −4.39 | −0.48 | 1.74 | 6.21 | 1.44 | 0.07 | −8.69 |
History of kidney disease or failure at time of survey | −16.60‡ | −2.48 | −0.91 | −14.12‡ | −12.07‡ | −3.82 | 13.86‡ | 18.38‡ |
Therapy received as treatment for primary cancer or recurrence | ||||||||
None (reference) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBRT alone | 0.74 | 1.38 | 0.13 | −2.00 | −2.48 | 2.04 | 2.21 | 0.98 |
Chemotherapy±EBRT | 0.28 | −4.44 | −3.15 | −5.40 | −10.24‡ | −3.75 | 5.83 | 2.23 |
Type of staging | ||||||||
SLN biopsy (reference) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
LND | 2.87 | 0.59 | 0.35 | 5.14‡ | 0.79 | 2.53 | −2.71 | −1.83 |
QoL scores range from 0 to 100.
Bold indicates clinically meaningful difference (≥10 points).
*Higher functional scores indicate better functional well-being.
†Higher symptom scores indicate worse symptom.
‡Statistically significant, p<0.05.
BMI, body mass index (kg/m2) at time of survey; EBRT, external beam radiation therapy; IPTW, inverse-probability of treatment weighting; LEL, lower extremity lymphedema; LND, lymphadenectomy; QoL, quality of life; SLN, sentinel lymph node.